All of findings above triggered us to clarify the pathogenetic role exerted by the non-canonical Wnt5a/JNK1 pathway, NF-κB, and COX-2 in NASH development. This evidence concerns the gene WNT5A and metabolic dysfunction-associated steatohepatitis.